Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iterum Therapeutics
Biotech
Iterum's UTI drug faces concerns about antimicrobial resistance
An FDA panel will flesh out concerns that use of Iterum's urinary tract infection treatment sulopenem could cause antimicrobial resistance.
Kevin Dunleavy
Sep 6, 2024 11:31am
Abbott CEO adds chair to title as White retires—Chutes & Ladders
Dec 17, 2021 9:30am
Former Iterum VP returns as medical lead to test UTI drug again
Dec 13, 2021 11:13am
FDA said no in July, so Iterum will test UTI antibiotic again
Sep 29, 2021 10:05am
From speedy review to standstill: FDA spurns Iterum's antibiotic
Jul 26, 2021 11:11am
FDA finds faults in Iterum filing as decision date looms
Jul 2, 2021 10:36am
